280 related articles for article (PubMed ID: 17450586)
41. Preparation, characterization and applications of low-molecular-weight alginate-oligochitosan nanocapsules.
Wang T; He N
Nanoscale; 2010 Feb; 2(2):230-9. PubMed ID: 20644799
[TBL] [Abstract][Full Text] [Related]
42. Hydrophobic modification of sodium alginate and its application in drug controlled release.
Yao B; Ni C; Xiong C; Zhu C; Huang B
Bioprocess Biosyst Eng; 2010 May; 33(4):457-63. PubMed ID: 19578877
[TBL] [Abstract][Full Text] [Related]
43. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
George M; Abraham TE
J Control Release; 2006 Aug; 114(1):1-14. PubMed ID: 16828914
[TBL] [Abstract][Full Text] [Related]
44. Interactions between bovine serum albumin and oxidized sodium alginate in solution.
Gao C; Liu M; Chen J; Chen C
J Biomater Sci Polym Ed; 2011; 22(12):1639-50. PubMed ID: 20699058
[TBL] [Abstract][Full Text] [Related]
45. Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property.
Yu CY; Yin BC; Zhang W; Cheng SX; Zhang XZ; Zhuo RX
Colloids Surf B Biointerfaces; 2009 Feb; 68(2):245-9. PubMed ID: 19058952
[TBL] [Abstract][Full Text] [Related]
46. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system.
Coppi G; Iannuccelli V
Int J Pharm; 2009 Feb; 367(1-2):127-32. PubMed ID: 18940240
[TBL] [Abstract][Full Text] [Related]
47. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate.
Wu Y; Yang W; Wang C; Hu J; Fu S
Int J Pharm; 2005 May; 295(1-2):235-45. PubMed ID: 15848008
[TBL] [Abstract][Full Text] [Related]
48. Development of a new calcium sulphate-based composite using alginate and chemically modified chitosan for bone regeneration.
d'Ayala GG; De Rosa A; Laurienzo P; Malinconico M
J Biomed Mater Res A; 2007 Jun; 81(4):811-20. PubMed ID: 17236217
[TBL] [Abstract][Full Text] [Related]
49. In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery.
Chen F; Zhang ZR; Yuan F; Qin X; Wang M; Huang Y
Int J Pharm; 2008 Feb; 349(1-2):226-33. PubMed ID: 17825506
[TBL] [Abstract][Full Text] [Related]
50. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
[TBL] [Abstract][Full Text] [Related]
51. Binding of chloroquine-conjugated gold nanoparticles with bovine serum albumin.
Joshi P; Chakraborty S; Dey S; Shanker V; Ansari ZA; Singh SP; Chakrabarti P
J Colloid Interface Sci; 2011 Mar; 355(2):402-9. PubMed ID: 21216410
[TBL] [Abstract][Full Text] [Related]
52. Biomineralized polysaccharide beads for dual-stimuli-responsive drug delivery.
Shi J; Liu L; Sun X; Cao S; Mano JF
Macromol Biosci; 2008 Mar; 8(3):260-7. PubMed ID: 18008299
[TBL] [Abstract][Full Text] [Related]
53. A novel pH sensitive N-succinyl chitosan/alginate hydrogel bead for nifedipine delivery.
Dai YN; Li P; Zhang JP; Wang AQ; Wei Q
Biopharm Drug Dispos; 2008 Apr; 29(3):173-84. PubMed ID: 18215011
[TBL] [Abstract][Full Text] [Related]
54. In situ generation of sodium alginate/hydroxyapatite nanocomposite beads as drug-controlled release matrices.
Zhang J; Wang Q; Wang A
Acta Biomater; 2010 Feb; 6(2):445-54. PubMed ID: 19596091
[TBL] [Abstract][Full Text] [Related]
55. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
Yeh MK; Cheng KM; Hu CS; Huang YC; Young JJ
Acta Biomater; 2011 Oct; 7(10):3804-12. PubMed ID: 21742066
[TBL] [Abstract][Full Text] [Related]
56. Optimization and characterization of chitosan-coated alginate microcapsules containing albumin.
Zheng CH; Liang WQ; Li F; Zhang YP; Fang WJ
Pharmazie; 2005 Jun; 60(6):434-8. PubMed ID: 15997832
[TBL] [Abstract][Full Text] [Related]
57. Development of amphoteric alginate/aminated chitosan coated microbeads for oral protein delivery.
Omer AM; Tamer TM; Hassan MA; Rychter P; Mohy Eldin MS; Koseva N
Int J Biol Macromol; 2016 Nov; 92():362-370. PubMed ID: 27392773
[TBL] [Abstract][Full Text] [Related]
58. Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules.
de la Fuente M; Seijo B; Alonso MJ
Macromol Biosci; 2008 May; 8(5):441-50. PubMed ID: 18236434
[TBL] [Abstract][Full Text] [Related]
59. Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization.
Qian F; Cui F; Ding J; Tang C; Yin C
Biomacromolecules; 2006 Oct; 7(10):2722-7. PubMed ID: 17025345
[TBL] [Abstract][Full Text] [Related]
60. Effect of the molecular mass and degree of substitution of oleoylchitosan on the structure, rheological properties, and formation of nanoparticles.
Li YY; Chen XG; Liu CS; Cha DS; Park HJ; Lee CM
J Agric Food Chem; 2007 Jun; 55(12):4842-7. PubMed ID: 17497792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
